Lexaria Bioscience Corp. vs Pharmicell Co., Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pharmicell Co., Ltd. is the larger company by market value: $514 M against $15 M for Lexaria Bioscience Corp., 34 times as much (market caps of Aug 1, 2026). Lexaria Bioscience Corp.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Lexaria Bioscience Corp. LEXX · #25,047 in the world | Pharmicell Co., Ltd. 005690.KS · #12,408 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇦 Canada | 🇰🇷 South Korea |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $15 M | $514 M |
| Revenue | $1 M | — |
| Net income | $-12 M | — |
| Valuation | ||
| Price to sales | 21.1× | — |
| Price to book | 5.0× | — |
| Free cash flow yield | -69.8% | — |
| Profitability | ||
| Return on equity | -215.8% | — |
| Altman Z-score zone | distress | — |
| Data as of | Market cap Aug 2026; ratios FY2025 | Market cap Aug 2026 |
Questions and answers#
Which is bigger, Lexaria Bioscience Corp. or Pharmicell Co., Ltd.?
Pharmicell Co., Ltd. is the larger company by market value: $514 M against $15 M for Lexaria Bioscience Corp., 34 times as much (market caps of Aug 1, 2026). Lexaria Bioscience Corp.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.